BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 181760)

  • 1. Antiviral activity of an extract of Brucella abortus: induction of interferon and immunopotentiation of host resistance.
    Kern ER; Glasgow LA; Overall JC
    Proc Soc Exp Biol Med; 1976 Jul; 152(3):372-6. PubMed ID: 181760
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protective action of double-stranded complexes--interferon inducers in encephalomyocarditis in mice].
    Nosik NN; Lavrukhina LA; Ershov FI
    Biull Eksp Biol Med; 1984 Apr; 97(4):446-8. PubMed ID: 6326886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. I. Effect of single doses of polyriboinosinic-polyribocytidylic acid and tilorone hydrochloride on viral pathogenesis.
    Stringfellow DA; Overall JC; Glasgow LA
    J Infect Dis; 1974 Nov; 130(5):470-80. PubMed ID: 4371528
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of interferon in the antiviral state elicited by selected interferon inducers.
    Giron DJ; Liu RY; Hemphill FE; Pindak FF; Schmidt JP
    Proc Soc Exp Biol Med; 1980 Jan; 163(1):146-50. PubMed ID: 6243412
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the prophylactic and therapeutic effects of poly I:C and endotoxin in mice infected with Mengo virus.
    Campbell JB; White SL
    Can J Microbiol; 1976 Nov; 22(11):1595-602. PubMed ID: 184902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of virus-induced diabetes mellitus by interferon is influenced by the host strain.
    Giron DJ; Cohen SJ; Lyons SP; Wharton CH; Cerutis DR
    Proc Soc Exp Biol Med; 1983 Jul; 173(3):328-31. PubMed ID: 6306672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in the contribution of induced interferon and adjuvanticity to the antiviral effect of different polyinosinic acid . polycytidylic acid formulations in mice infected with encephalomyocarditis virus.
    Stebbing N; Lindley IJ; Dawson KM
    Infect Immun; 1980 Sep; 29(3):960-5. PubMed ID: 6253403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the anti-viral mechanism of poly I and poly C against encephalomyocarditis virus infection in the absence of interferon induction in mice.
    Stebbing N; Grantham CA; Kaminski F
    J Gen Virol; 1976 Jul; 32(1):25-35. PubMed ID: 182913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-viral activity of single-stranded homopolynucleotides against encephalomyocarditis virus and Semliki Forest virus in adult mice without interferon induction.
    Stebbing N; Grantham CA; Carey NH
    J Gen Virol; 1976 Jan; 30(1):21-39. PubMed ID: 173799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon induction in mice by lipopolysaccharide from Brucella abortus.
    Keleti G; Feingold DS; Youngner JS
    Infect Immun; 1974 Jul; 10(1):282-3. PubMed ID: 4210341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of Brucella abortus preparations; separation of active components.
    Feingold DS; Keleti G; Youngner JS
    Infect Immun; 1976 Mar; 13(3):763-7. PubMed ID: 818014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of murine interferon by a substituted pyrimidine.
    Nichol FR; Weed SD; Underwood GE
    Antimicrob Agents Chemother; 1976 Mar; 9(3):433-9. PubMed ID: 176934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of antiviral protection against encephalomyocarditis virus by a combination of isoprinosine and interferon.
    Chany C; Cerutti I
    Arch Virol; 1977; 55(3):225-31. PubMed ID: 74245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activity of an ether-extracted nonviable preparation of Brucella abortus.
    Youngner JS; Keleti G; Feingold DS
    Infect Immun; 1974 Dec; 10(6):1202-6. PubMed ID: 4373393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mathematical planning of an experiment for assessing the combined action of new interferon inducers].
    Saĭitkulov AM; Chizhov NP; Churnosov EV; Ershov FI
    Vopr Virusol; 1985; 30(5):617-9. PubMed ID: 3000087
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined protective effects on interferon and interferon induction on herpes simplex and ectromelia virus infections in mice.
    Imanishi J; Matsubara M; Won CJ; Nomura H; Kishida T
    Antimicrob Agents Chemother; 1981 May; 19(5):922-4. PubMed ID: 6170256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressed response to interferon inducation in mice infected with encephalomyocarditis virus, Semliki forest virus, influenza A2 virus, Herpesvirus hominis type 2, or murine cytomegalovirus.
    Stringfellow DA; Kern ER; Kelsey DK; Glasgow LA
    J Infect Dis; 1977 Apr; 135(4):540-51. PubMed ID: 192804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments in the therapy of ocular herpes simplex.
    Pavan-Langston D
    Int Ophthalmol Clin; 1973; 13(4):53-63. PubMed ID: 4784004
    [No Abstract]   [Full Text] [Related]  

  • 19. [Accelerated method of determining the antiviral activity of interferon inducers in experimental infection].
    Novokhatskiĭ AS; Cherkashina NP; Ershov FI
    Vopr Virusol; 1979; (3):303-6. PubMed ID: 462928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed recovery from herpes.
    Roach ES; Abramson J
    Pediatr Infect Dis; 1985; 4(6):703. PubMed ID: 4080594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.